DONGSUNG PHARMACEUTICAL (002210)

KOSPI · 1,534 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

1,0001,2001,4001,6001,800 H 1,846L 973 25.0826.0526.08
Mkt Cap
148.2B
PBR
6.34
52W
0K~1K

DONGSUNG PHARMACEUTICAL operates in the Pharmaceuticals sector.

Legal name: DONGSUNG PHARMACEUTICAL CO.,LTD

As of the Aug 26, 2026 close, the market capitalization was 148.2 billion KRW, with a P/B of 6.34.

These figures can be verified in the DART filing (receipt no. 20260506000554).

Checks

5 applicable out of 8 items

Check details →

Recent Filings

Large Group Status Disclosure (Quarterly Disclosure Individual)

Semi-Annual Report (2026.06)

Payment and Dispute Resolution

All filings →

Checks

5 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: No administrative designation criteria met.

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: Convertible bonds outstanding with 0.4% potential dilution.
Capital Increase: 1 capital-increase filing(s) in the last 180 days. [source]

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: 6 embezzlement/litigation filing(s) in the last 180 days. [source]
Major Shareholder Change: 2 major shareholder change(s) in the last 180 days. [source]
Market Action: 3 market action(s) (trading halt, delisting, etc.) recorded. [source]
These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Recent Filings

DateFiling
2026-08-27Large Group Status Disclosure (Quarterly Disclosure Individual)
2026-08-14Semi-Annual Report (2026.06)
2026-08-14Payment and Dispute Resolution
2026-07-29Other Business Matters (Voluntary Disclosure)
2026-07-29기타시장안내 (유가증권시장 상장공시위원회 심의결과 및 상장유지 결정)